References
- S. C. Lee, Y.J. Kim &.(2017). Dosimetric comparision for rectal cancer using 3D-CRT, IMRT, Tomotherapy. J Korean Soc of Radiol, 11(5), 393-399. DOI : 10.7742/jksr.2017.11.5.393
- D. R. Olsen, O. S. Bruland &.(2007). Proton therapy - a systematic review of clinical effectiveness. Radiother Oncol. 83(2).123-132. DOI : 10.1016/j.radonc.2007.03.001
- P. Blanchard, G. B. Gunn &. (2018). Proton Therapy for Head and Neck Cancers. Semin Radiat Oncol. 28(1), 53-63. DOI : 10.1016/j.semradonc.2017.08.004
- L. Widesott, M. Amichetti &.(2008). Proton therapy in lung cancer: clinical outcomes and technical issues. A systematic review. Radiother Oncol . 86(2). 154-164. DOI : 10.1016/j.radonc.2008.01.003
- S. E. Combs, N. Laperriere &.(2013). Clinical controversies: proton radiation therapy for brain and skull base tumors. Semin Radiat Oncol.23(2).120-126. DOI : 10.1016/j.semradonc.2012.11.011
- E. B. Hug, M. W. Muenter &.(2002). Conformal proton radiation therapy for pediatric low-grade astrocytomas. Strahlenther Onkol. 178(1).10-17 https://doi.org/10.1007/s00066-002-0874-2
- M. Mizumoto, H. Nakayama &.(2010). Technical considerations for noncoplanar proton-beam therapy of patients with tumors proximal to the optic nerve. Strahlenther Onkol. 186(1), 36-39. DOI : 10.1007/s00066-009-2019-3
- M. Mizumoto, K. Tsuboi &.(2010). Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 77(1), 98-105. DOI : 10.1016/j.ijrobp.2009.04.054
- B. B. Ronson, R. W. Schulte &.(2006). Fractionated proton beam irradiation of pituitary adenomas. Int J Radiat Oncol Biol Phys. 64(2), 425-434. DOI : 10.1016/j.ijrobp.2005.07.978
- D. A. Bush, C. J. McAllister &..(2002). Fractionated proton beam radiotherapy for acoustic neuroma. Neurosurgery. 50(2).270-273; discussion 273-275 https://doi.org/10.1227/00006123-200202000-00007
- A. M. Allen, T. Pawlicki &.(2012). An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee. Radiother Oncol. 103(1), 8-11. DOI : 10.1016/j.radonc.2012.02.001
- S. H. Lee, K. H. Cho &.(2018). Clinical outcome of proton therapy for patients with chordomas. Radiot Oncol J. 36(3), 182-191.10.3857/roj.2018.00164
- J. E. Munzenrider, N. J. Liebsch &.(1999). Proton therapy for tumors of the skull base. Strahlenther Onkol. 175 Suppl 2(57-63
- L. Feuvret, S. Bracci &.(2016). Efficacy and Safety of Adjuvant Proton Therapy Combined With Surgery for Chondrosarcoma of the Skull Base: A Retrospective, Population-Based Study. Int J Radiat Oncol Biol Phys. 95(1), 312-321. DOI : 10.1016/j.ijrobp.2015.12.016
- Y. J. Choi, T. W. Kim &.(2018). J Korean Med Sci. 33(16), e120 DOI : 10.3346/jkms.2018.33.e120
- M. Takagi, Y. Demizu &.(2017). Long-term outcomes in patients treated with proton therapy for localized prostate cancer. Cancer Med. 6(10), 2234-2243. DOI : 10.1002/cam4.1159
- K. Nihei, T. Ogino &.(2011). Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities. Int J Radiat Oncol Biol Phys. 81(2), 390-396.10. DOI : 1016/j.ijrobp.2010.05.027 https://doi.org/10.1016/j.ijrobp.2010.05.027
- N. P. Mendenhall, Z. Li &.(2012). Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 82(1), 213-221. DOI : 10.1016/j.ijrobp.2010.09.024
- N. C. Sheets, G. H. Goldin &.(2012). Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA. 307(15, .1611-1620. DOI : 10.1001/jama.2012.460
- S. LEE, Y. J. Cao &.(2015). Treatment plan comparison of Linac step and shoot, Tomotherapy, RapidArc, and proton therapy for prostate cancer using dosimetrical and biological index. Journal of the Korean Physical Society. 73(6), 684-700 DOI : 10.3938/jkps.67.7
- M. A. L. Vyfhuis, N. Onyeuku &.(2018). Advances in proton therapy in lung cancer. Ther Adv Respir Dis. 12(1753466618783878. DOI : 10.1177/1753466618783878
- S. Sejpal, R. Komaki &.(2011). Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer. Cancer. 117(13), 3004-3013. DOI : 10.1002/cncr.25848
- F. Dionisi, L. Widesott &.(2014). Is there a role for proton therapy in the treatment of hepatocellular carcinoma? A systematic review. Radiother Oncol. 111(1), 1-10.10. DOI : 1016/j.radonc.2014.02.001 https://doi.org/10.1016/j.radonc.2014.02.001
- T. Chiba, K. Tokuuye &.(2005). Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Clin Cancer Res. 11(10), 3799-3805. DOI : 10.1158/1078-0432.CCR-04-1350
- S. Komatsu, T. Fukumoto &.(2011). Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma. Cancer. 117(21), 4890-4904. DOI : 10.1002/cncr.26134
- D. H. Lim. (2018). Radiation therapy against peiatric malignant central nervous system tumors : Embryonal tumors and proton beam therapy. J Korean Neurosurg Soc. 61(3), 386-392. DOI : 10.3340/jkns.2018.0004
- R. Leroy, N. Benahmed &.(2016). Proton Therapy in Children: A Systematic Review of Clinical Effectiveness in 15 Pediatric Cancers. Int J Radiat Oncol Biol Phys. 95(1), 267-278. DOI : 10.1016/j.ijrobp.2015.10.025
- T. E. Merchant &.(2013). Clinical controversies: proton therapy for pediatric tumors. Semin Radiat Oncol. 23(2), 97-108. DOI : 10.1016/j.semradonc.2012.11.008
- B. Rombi, T. F. DeLaney &.(2012). Proton radiotherapy for pediatric Ewing's sarcoma: initial clinical outcomes. Int J Radiat Oncol Biol Phys. 82(3), 1142-1148. DOI : 10.1016/j.ijrobp.2011.03.038
- D. C. Weber, J. L. Habrand.(2018). Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN. Radiother Oncol. 128(1), 44-55.10. DOI : 1016/j.radonc.2018.05.020 https://doi.org/10.1016/j.radonc.2018.05.020